Darwin Global Management, Ltd.
CIK
1839209
Location
ST. HELIER, Y9
Portfolio Value
Mid
$4,026,455,721
Diversification
Highly concentrated
Filing Date
Global Rank
#776
/ 8,605
▼ 52
· as of Mar 2026
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-15.7%
Period ended 3 months ago
Filed May 15, 2026 · 55d
19 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+14.5%
SPY
+76.5%
Annualised alpha
-16.3%
Max drawdown
−50.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
6 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
68.2%
−9.2 pts
Top 5
100.0%
−0.0 pts
Top 10
100.0%
0.0 pts
HHI
4,947
Highly concentrated−1,250
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $4,026,455,721 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| INSM | INSMED Inc | −4,128,093 | 16,805,184 | $2,747,983,687 | |
| No positions match the current search. | |||||
6 positions ·
$4,026,455,721 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| INSM |
INSMED Inc
Healthcare
|
Reduced | 16,805,184 | $2,747,983,687 | 68.25% | |
| BLTE |
Belite Bio, Inc
Healthcare
|
Reduced | 3,057,412 | $487,473,769 | 12.11% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 3,468,657 | $386,234,956 | 9.59% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
NEW | 2,211,018 | $215,021,500 | 5.34% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
NEW | 6,797,300 | $188,285,210 | 4.68% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
NEW | 17,357 | $1,456,599 | 0.04% |